Table 4.
Macrovesicular steatosis | |||
---|---|---|---|
None | Mild | Moderate | |
(0%) | (1–30%) | (31–60%) | |
Sevoflurane group, n | 9 | 16 | 5 |
Control group, n | 9 | 15 | 6 |
Macrovesicular steatosis | |||
---|---|---|---|
None | Mild | Moderate | |
(0%) | (1–30%) | (31–60%) | |
Sevoflurane group, n | 9 | 16 | 5 |
Control group, n | 9 | 15 | 6 |